Skip to main content
main-content

19.01.2017 | Research Article | Ausgabe 7/2017 Open Access

Clinical and Translational Oncology 7/2017

Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies

Zeitschrift:
Clinical and Translational Oncology > Ausgabe 7/2017
Autoren:
R. Vera, A. Ferrández, C. J. Ferrer, C. Flores, C. Joaquín, S. López, T. Martín, E. Martín, M. Marzo, A. Sarrión, E. Vaquero, A. Zapatero, J. Aparicio
Wichtige Hinweise
The original version of this article was revised due to a retrospective Open Access order.
This Pan-TIME Consensus is being simultaneously published in the journals from the scientific societies that have participated on the consensus statement.
An erratum to this article is available at http://​dx.​doi.​org/​10.​1007/​s12094-017-1636-z.

Abstract

Purpose

Pancreatic cancer (PC) is a disease with bad prognosis. It is usually diagnosed at advanced stages and its treatment is complex. The aim of this consensus document was to provide recommendations by experts that would ameliorate PC diagnosis, reduce the time to treatment, and optimize PC management by interdisciplinary teams.

Methods

As a consensus method, we followed the modified Delphi methodology. A scientific committee of experts provided 40 statements that were submitted in two rounds to a panel of 87 specialists of 12 scientific societies.

Results

Agreement was reached for 39 of the 40 proposed statements (97.5%).

Conclusions

Although a screening of the asymptomatic population is not a feasible option, special attention to potential symptoms during primary care could ameliorate early diagnostic. It is especially important to decrease the period until diagnostic tests are performed. This consensus could improve survival in PC patients by decreasing the time to diagnose and time to treatment and by the implementation of multidisciplinary teams.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 7/2017

Clinical and Translational Oncology 7/2017 Zur Ausgabe
  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

  2. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise